Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CAH 
Cardinal Health Inc (CAH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/10/2025: CAH (3-star) is a STRONG-BUY. BUY since 122 days. Profits (31.63%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
17 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $172.21
1 Year Target Price $172.21
| 9 | Strong Buy |
| 2 | Buy |
| 5 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 37.65% | Avg. Invested days 51 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 07/10/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 39.25B USD | Price to earnings Ratio 25.71 | 1Y Target Price 172.21 |
Price to earnings Ratio 25.71 | 1Y Target Price 172.21 | ||
Volume (30-day avg) 17 | Beta 0.68 | 52 Weeks Range 91.73 - 168.44 | Updated Date 07/9/2025 |
52 Weeks Range 91.73 - 168.44 | Updated Date 07/9/2025 | ||
Dividends yield (FY) 1.22% | Basic EPS (TTM) 6.39 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.7% | Operating Margin (TTM) 1.33% |
Management Effectiveness
Return on Assets (TTM) 3.13% | Return on Equity (TTM) - |
Valuation
Trailing PE 25.71 | Forward PE 17.76 | Enterprise Value 43558084841 | Price to Sales(TTM) 0.18 |
Enterprise Value 43558084841 | Price to Sales(TTM) 0.18 | ||
Enterprise Value to Revenue 0.2 | Enterprise Value to EBITDA 14.4 | Shares Outstanding 238676992 | Shares Floating 238225905 |
Shares Outstanding 238676992 | Shares Floating 238225905 | ||
Percent Insiders 0.26 | Percent Institutions 89.38 |
Upturn AI SWOT
Cardinal Health Inc
Company Overview
History and Background
Cardinal Health was founded in 1971 as Cardinal Foods, a food wholesaler. It entered the drug distribution business in 1979 and grew through acquisitions. Over time, it evolved into a healthcare services company focused on distribution of pharmaceuticals and medical products.
Core Business Areas
- Pharmaceutical Segment: This segment distributes branded and generic pharmaceutical products, specialty pharmaceuticals, and over-the-counter healthcare products to pharmacies, hospitals, and healthcare providers. It also provides services to pharmaceutical manufacturers.
- Medical Segment: This segment distributes medical, surgical, and laboratory products to hospitals, surgery centers, clinical laboratories, and other healthcare providers. It also manufactures medical products.
Leadership and Structure
The leadership team is headed by the CEO, Jason Hollar. The company has a functional organizational structure with different business segments and support functions.
Top Products and Market Share
Key Offerings
- Pharmaceutical Distribution: Cardinal Health distributes a wide range of pharmaceuticals to pharmacies, hospitals, and healthcare providers. Market share is significant in the pharmaceutical distribution market, competing with McKesson and AmerisourceBergen. Competitors are McKesson (MCK) and AmerisourceBergen (ABC).
- Medical Products: Cardinal Health manufactures and distributes medical, surgical, and laboratory products. Competitors are Medline Industries, Owens & Minor (OMI), and BD (BDX).
- OptiFreight Logistics: Provides logistics and supply chain solutions for the healthcare industry.
Market Dynamics
Industry Overview
The healthcare industry is experiencing growth due to the aging population, increasing prevalence of chronic diseases, and advancements in medical technology. Regulatory changes and consolidation are also key factors.
Positioning
Cardinal Health is a major player in the pharmaceutical and medical products distribution industry. Its competitive advantages include its extensive distribution network, strong relationships with manufacturers and providers, and supply chain expertise.
Total Addressable Market (TAM)
The TAM for pharmaceutical distribution and medical products is estimated to be in the hundreds of billions of dollars. Cardinal Health holds a substantial position, competing with other major distributors for market share.
Upturn SWOT Analysis
Strengths
- Large Distribution Network
- Strong Relationships with Suppliers and Customers
- Broad Product Portfolio
- Supply Chain Expertise
- Established Brand Reputation
Weaknesses
- Exposure to Generic Drug Pricing Pressure
- Dependence on Large Customers
- Litigation and Regulatory Risks
- Debt Levels
- Operational Inefficiencies
Opportunities
- Growth in Specialty Pharmaceuticals
- Expansion into Emerging Markets
- Increased Demand for Healthcare Services
- Technological Advancements in Supply Chain Management
- Acquisitions of Smaller Companies
Threats
- Increased Competition
- Regulatory Changes and Healthcare Reform
- Drug Pricing Pressure
- Economic Downturn
- Supply Chain Disruptions
Competitors and Market Share
Key Competitors
- McKesson Corporation (MCK)
- AmerisourceBergen Corporation (ABC)
- Cencora Corporation (COR)
Competitive Landscape
Cardinal Health competes with McKesson and AmerisourceBergen in the pharmaceutical distribution market. Competition is based on price, service, and distribution network.
Major Acquisitions
Medtronic's Patient Recovery Business
- Year: 2022
- Acquisition Price (USD millions): 610
- Strategic Rationale: Expanded Cardinal Health's medical products portfolio.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been a mix of organic growth and acquisitions.
Future Projections: Analyst estimates vary, but generally project moderate growth.
Recent Initiatives: Recent initiatives include focusing on strategic growth areas, improving operational efficiency, and managing costs.
Summary
Cardinal Health is a major player in healthcare distribution with a strong network, but faces challenges from pricing pressures and competition. Its large distribution footprint is an advantage, but it needs to manage debt and adapt to market changes. Recent acquisitions aim to fuel growth, but regulatory and litigation risks remain. Overall the company is moderately strong but will need to look out for economic down turn and pricing pressures.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Company Investor Relations
- Market Research Reports
- Analyst Estimates
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cardinal Health Inc
Exchange NYSE | Headquaters Dublin, OH, United States | ||
IPO Launch date 1987-12-31 | CEO & Director Mr. Jason M. Hollar | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 47922 | Website https://www.cardinalhealth.com |
Full time employees 47922 | Website https://www.cardinalhealth.com | ||
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.